Search

Your search keyword '"Alejandro, Mercedes E."' showing total 90 results

Search Constraints

Start Over You searched for: Author "Alejandro, Mercedes E." Remove constraint Author: "Alejandro, Mercedes E."
90 results on '"Alejandro, Mercedes E."'

Search Results

1. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples

2. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

3. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects

4. Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis

5. IgG4‐related disease: Association with a rare gene variant expressed in cytotoxic T cells

6. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

7. IRF2BPL Is Associated with Neurological Phenotypes

8. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

9. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

10. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

11. EFEMP1 haploinsufficiency causes a Marfan‐like hereditary connective tissue disorder.

12. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

13. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

14. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma

15. H4C5 missense variant leads to a neurodevelopmental phenotype overlapping with Angelman syndrome.

16. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

17. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

18. One is the loneliest number: genotypic matchmaking using the electronic health record

19. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

20. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

21. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

22. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

23. Genetic counselor roles in the undiagnosed diseases network research study: Clinical care, collaboration, and curation.

24. Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic disease.

25. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

26. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

27. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

28. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region

29. Expanding the Spectrum of BAF-Related Disorders : De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

30. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts

31. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

32. Detection of a mosaic CDKL5 deletion and inversion by optical genome mapping ends an exhaustive diagnostic odyssey.

33. Progressive cerebellar atrophy in a patient with complex II and III deficiency and a novel deleterious variant in SDHA: A Counseling Conundrum.

34. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

35. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

36. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

37. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

38. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative

39. Model organisms contribute to diagnosis and discovery in the undiagnosed diseases network: current state and a future vision.

40. A resource of lipidomics and metabolomics data from individuals with undiagnosed diseases.

41. Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice.

42. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

43. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.

44. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

45. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

46. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases

47. Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder

48. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

49. MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome

50. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

Catalog

Books, media, physical & digital resources